News Articles

Trading Room

100+ Years of combined Market Experience!


Homology Medicines: Novel Homologous Non-nuclease Gene Editing Technology

Homology Medicines (FIXX) is a gene editing company that has a novel AAV-HSCs technology which was licensed from the City of Hope Med Center.
by Bhavneesh Sharma - 3 days ago


Why I Am A Commodity Bull

I view the current environment of falling US rates, a rising dollar, economic growth in the US, and uncertainty over trade as a complicated backdrop for the commodities market which could lead to some wild price swings.
by Andy Hecht - 4 days ago


Atara Bio: Another Attractive Name in Allogeneic CAR-T Space

The company’s key developmental program is focused on developing off-the-shelf allogeneic T cell therapies against certain malignancies.
by Bhavneesh Sharma - 4 days ago


Trade War Update

The daily tweeting and trade news have figured prominently in recent market action.
by Jeff Miller - 4 days ago


Reversal in the Dollar on Weekly Chart

he dollar index appears poised to make a bullish key reversal trading pattern on the weekly chart this week.
by Andy Hecht - 4 days ago


The Economy May Be Moving Into A Vulnerable Window

Today there were several notable data releases including the ever important industrial production report, one of the factors in the four-factor coincident index, as well as the widely followed retail sales report.
by Eric Basmajian - 1 week ago


Permian Focused Oil Stocks To Buy Now

With Chevron bowing out on the Anadarko battle with Occidental, that leaves quite a few companies in play again.
by Kirk Spano - 1 week ago


While Oil Prices Weaken, Geopolitics Scream Higher

While the market may interpret any reduction in output cuts as bearish, the situation in the Middle East should keep the bid under the price of crude oil.
by Andy Hecht - 1 week ago


Put Discover Financial Services On Your Radar

Put Discover Financial Services on your radar. It’s a strong, profitable, well-managed company that survived the global financial crisis on much better terms than many other financial companies. And yet, it’s very volatile and prone to big drawdowns. Buying during those drawdowns can be very lucrative for patient investors.
by Lyn Alden Schwartzer - 1 week ago

Shaping Up For A Wild Market

The structure of the market action we are seeing is certainly suggesting to me that the market is attempting to develop a larger degree top.
by Avi Gilburt - 1 week ago

Who's Buying Bitcoin Now?

As the infrastructure continues to develop and grow in sophistication, we’ll see more institutions consider crypto as an asset base.
by Ryan Wilday - 1 week ago


CRISPR Therapeutics (CRSP): Novel gene editing approach in CAR-T therapy

CRISPR Therapeutics's approach to developing allogeneic CAR-T cells involves multiple steps to overcome these challenges presented by solid tumors.
by Bhavneesh Sharma - 2 weeks ago


Economic Impact of a Tariff Increase

What is the impact of a US tariff hike on China? Here is one estimate of the effects.
by Jeff Miller - 2 weeks ago

Tariff News - Market Analysis on May 5th, 2019

President Trump tweeted plans to proceed with the increase of tariffs on Chinese imports from 10% to 25% -- supposedly on Friday.
by Jeff Miller - 2 weeks ago


A Week’s Vacation- A Refreshed View Of Commodities

Unfortunately, it feels like the current malaise is likely to continue to frustrate those looking for significant moves in the commodities sector or any other markets across most asset classes.
by Andy Hecht - 2 weeks ago


Thailand Market: A Blend of Growth and Value

The Kingdom of Thailand represents well under 1% of world market capitalization, which makes it an easy market to overlook.
by Lyn Alden Schwartzer - 2 weeks ago


Analyzing The Employment Report

The employment report that was published on Friday was similar to the Q1 GDP report in that the headline number was "strong" and better than expectations while the numbers under the surface showed signs of continued economic deceleration.
by Eric Basmajian - 2 weeks ago


What Is A Good Trade?

The popular perception is that a good trade is one where your purchase goes up after a buy and down after a sale.
by Jeff Miller - 2 weeks ago


Employment Report -- Early Take

My early look at the employment report suggests that, while good, it is not as good as the headline number suggests.
by Jeff Miller - 2 weeks ago

chart And Norway Are Beating Down Oil And Gas Stocks – For Now

What we have seen for the last few quarters is an acceleration of the fossil fuel divestiture movement due to the climate change thesis of many fiduciaries.
by Kirk Spano - 2 weeks ago


FOMC Meeting Reaction

Investors would do better to ignore the small changes in possible Fed policy. Spend your time finding stocks that do well in a solid economy with low interest rates.
by Jeff Miller - 2 weeks ago


As a Value Investor, These Are The 2 Gold Charts I Focus On

I usually include an allocation to gold and gold stocks in my portfolio. Gold is a mostly non-correlated asset class to stocks, which makes it useful for improving risk-adjusted returns, and it can potentially serve well for defensive positioning in some contexts.
by Lyn Alden Schwartzer - 2 weeks ago

$GOOG - Miss on Ad Revenue Update

There will be changes coming across all ad companies -- Google was the first to show these signs.
by Beth Kindig - 3 weeks ago


Why Moderna (MRNA) Could Revolutionize the Way We Treat Cancers

In this second article in a 2-part series, my focus will be describing the oncology pipeline of Moderna Therapeutics, which I consider as one of the large future revenue drivers.
by Bhavneesh Sharma - 3 weeks ago

Fallacies About Gold Continue

If high prices would cause people to be bullish, why would anyone ever sell at high prices if those prices are what make people bullish.
by Avi Gilburt - 3 weeks ago

Sign Up Now - Free 15-Day Trial! Go! Fatty!